Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis

Nephrology Dialysis Transplantation

Volumn 21, Issue 7, 2006, Pages 1825-1832

  Marinaki, Smaragdi ^a   Kälsch, Anna Isabelle ^a   Grimminger, Peter ^a   Breedijk, Annette ^a   Birck, Rainer ^a   Schmitt, Wilhelm H ^a   Weiss, Christel ^a   van der Woude, Fokko J ^a   Yard, Benito A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ANCA associated vasculitis; Clinical correlation; Persistence; T cell activation

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CD28 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL PEPTIDASE IV; ETANERCEPT; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGE DISTRIBUTION; ANCA ASSOCIATED VASCULITIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES; VASCULITIS;

EID: 33745608718     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl097     Document Type: Article

References (19)

1. van der Woude F, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-429
2. Falk R, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119
3. Rarok A, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 2003; 74: 3-15
4. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 919-921
5. Brouwer E, Stegeman CA, Hiutema MG, Limburg PC, Kallenberg CG. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994; 98: 448-453
6. Cunningham M, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 1999; 10: 499-506
7. Schmitt W, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 1992; 35: 1088-1096
8. Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997; 102: 517-523
9. Lockwood C, Thiru S, Isaacs JD, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993; 341: 1620-1622
10. Schmitt W, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ; European Vasculitis Study Group. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients. Kidney Int 2004; 65: 1440-1448
11. Popa E, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999; 103: 885-89
12. Popa E, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol 2003; 132: 496-504
13. Marinaki S, Neumann I, Kälsch A-I et al. Abnormalities of CD4T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 2005; 140: 181-191
14. Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM. Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int 2003; 63: 2144-2151
15. Lamprecht P, Vargas Cuero AL, Muller A et al. Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis. Cell Immunol 2003; 224: 1-7
16. Schlesier M, Kaspar T, Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. Rheumatol Int 1995; 14: 213-219
17. Giscombe R, Nityanand S, Lewin N, Grunewald J, Lefvert AK. Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J Clin Immunol 1998; 18: 404-413
18. Stohne JH, Wegeners Granulomatosis Etanercept Trial Research Group. Limited versus Severe Wegener's Granulomatosis. Arthritis Rheum 2003; 48: 2299-2309
19. Birck R, Schmitt WH, Kaelsch IA, van der Woude FJ. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: Systematic review. Am J Kidney Dis 2006; 47: 15-23